The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Krognes Steve E. since 2019.
This trader's CIK number is 1666236.
At the time of last reporting, Krognes Steve E. was the Director of Guardant Health, Inc.. (stock ticker symbol GH).
Also see all insider trading activities at Guardant Health, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | GH | 0 | $0 | 0 | $0 | 7,908 | $0 |
| 2024 | GH | 0 | $0 | 0 | $0 | 7,443 | $0 |
| 2023 | GH | 0 | $0 | 0 | $0 | 2,622 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DNLI | 0 | $0 | 3,339 | $69,484 | 0 | $0 |
| 2024 | DNLI | 0 | $0 | 68,373 | $1,710,654 | 0 | $0 |
| 2023 | DNLI | 0 | $0 | 7,885 | $222,837 | 0 | $0 |
| 2022 | DNLI | 0 | $0 | 4,785 | $188,374 | 62,500 | $42,500 |
| 2021 | DNLI | 0 | $0 | 156,768 | $10,411,596 | 4,250 | $0 |
| 2020 | DNLI | 0 | $0 | 1,428 | $27,817 | 5,643 | $0 |
| 2019 | DNLI | 0 | $0 | 0 | $0 | 5,643 | $0 |
2. Denali Therapeutics Inc. (DNLI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-31 | GH | Option Ex | 155 | .00 | 0 |
| 2025-07-31 | GH | Option Ex | 154 | .00 | 0 |
| 2025-06-30 | GH | Option Ex | 154 | .00 | 0 |
| 2025-06-12 | GH | Option Ex | 6,674 | .00 | 0 |
| 2025-05-31 | GH | Option Ex | 154 | .00 | 0 |
| 2025-04-30 | GH | Option Ex | 155 | .00 | 0 |
| 2025-03-31 | GH | Option Ex | 154 | .00 | 0 |
| 2025-02-28 | GH | Option Ex | 154 | .00 | 0 |
| 2025-01-31 | GH | Option Ex | 154 | .00 | 0 |
| 2024-11-30 | GH | Option Ex | 154 | .00 | 0 |
| 2024-10-31 | GH | Option Ex | 154 | .00 | 0 |
| 2024-09-30 | GH | Option Ex | 154 | .00 | 0 |
| 2024-08-31 | GH | Option Ex | 155 | .00 | 0 |
| 2024-07-31 | GH | Option Ex | 154 | .00 | 0 |
| 2024-06-30 | GH | Option Ex | 154 | .00 | 0 |
| 2024-06-12 | GH | Option Ex | 5,592 | .00 | 0 |
| 2024-05-31 | GH | Option Ex | 155 | .00 | 0 |
| 2024-04-30 | GH | Option Ex | 154 | .00 | 0 |
| 2024-03-31 | GH | Option Ex | 154 | .00 | 0 |
| 2024-02-29 | GH | Option Ex | 154 | .00 | 0 |
| 2024-01-31 | GH | Option Ex | 155 | .00 | 0 |
| 2023-12-31 | GH | Option Ex | 154 | .00 | 0 |
| 2023-11-30 | GH | Option Ex | 154 | .00 | 0 |
| 2023-10-31 | GH | Option Ex | 154 | .00 | 0 |
| 2023-09-30 | GH | Option Ex | 155 | .00 | 0 |
| 2023-08-31 | GH | Option Ex | 154 | .00 | 0 |
| 2023-07-31 | GH | Option Ex | 154 | .00 | 0 |
| 2023-06-30 | GH | Option Ex | 1,851 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-07 | DNLI | Sale | 3,339 | 20.81 | 69,484 |
| 2024-09-30 | DNLI | Sale | 30,000 | 29.03 | 870,900 |
| 2024-08-20 | DNLI | Sale | 1,727 | 23.79 | 41,085 |
| 2024-06-13 | DNLI | Sale | 688 | 21.79 | 14,991 |
| 2024-07-01 | DNLI | Sale | 30,000 | 22.46 | 673,800 |
| 2024-02-13 | DNLI | Sale | 2,750 | 17.29 | 47,547 |
| 2024-01-05 | DNLI | Sale | 3,208 | 19.43 | 62,331 |
| 2023-08-21 | DNLI | Sale | 1,419 | 22.60 | 32,069 |
| 2023-02-13 | DNLI | Sale | 2,119 | 30.10 | 63,781 |
| 2023-02-08 | DNLI | Sale | 1,377 | 30.88 | 42,521 |
| 2023-01-05 | DNLI | Sale | 2,970 | 28.44 | 84,466 |
| 2022-07-19 | DNLI | Option Ex | 62,500 | .68 | 42,500 |
| 2022-02-11 | DNLI | Sale | 2,560 | 34.69 | 88,806 |
| 2022-01-05 | DNLI | Sale | 2,225 | 44.75 | 99,568 |
| 2021-08-19 | DNLI | Sale | 2,285 | 49.80 | 113,781 |
| 2021-03-15 | DNLI | Sale | 50,000 | 62.40 | 3,119,850 |
| 2021-02-16 | DNLI | Sale | 50,000 | 65.58 | 3,278,900 |
| 2021-02-11 | DNLI | Sale | 3,035 | 70.80 | 214,881 |
| 2021-02-09 | DNLI | Sale | 1,448 | 74.89 | 108,434 |
| 2021-02-07 | DNLI | Option Ex | 4,250 | .00 | 0 |
| 2021-01-15 | DNLI | Sale | 50,000 | 71.52 | 3,575,750 |
| 2020-08-20 | DNLI | Option Ex | 5,643 | .00 | 0 |
| 2020-03-30 | DNLI | Sale | 1,428 | 19.48 | 27,817 |
| 2019-08-20 | DNLI | Option Ex | 5,643 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Krognes Steve E. (Director of Guardant Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.